I now have comprehensive data from authoritative textbooks and recent meta-analyses. Here is a thorough answer:
Kidney Donor Comparison: 75-Year-Old Mother (Same Blood Group) vs. Wife (Different Blood Group)
Bottom Line
The wife with a different blood group is the better donor, provided she is younger (presumably 30s-50s), medically fit, and willing to undergo desensitization. Age of the donor is a more powerful predictor of long-term graft survival than ABO compatibility, and ABO incompatibility is now a manageable (though not trivial) barrier.
1. Why Donor Age Matters So Much
From Brenner and Rector's The Kidney:
"Older kidney donor age is associated with reduced kidney transplant survival. A donor age effect is apparent among deceased and living donor transplants. These results are thought to reflect a higher incidence of delayed graft function (DGF) and of nephron 'underdosing.' Allografts from older donors have fewer functioning nephrons because of the aging process and donor-related conditions such as hypertension and atherosclerosis."
- Graft survival was significantly higher in recipients of kidneys from donors aged <60 vs. >60.
- Risk of acute rejection was lower (RR 0.62, 95% CI 0.5-0.8) with younger donors.
- Risk of delayed graft function was dramatically lower (RR 0.28, 95% CI 0.1-0.9) with younger donors.
- 1-year serum creatinine was significantly lower with donors <60 years.
A 75-year-old donor is well above the critical threshold. Most US transplant centers cap living donors at 65 years. While the National Kidney Foundation Primer notes that some older living donors (>55 years) can achieve graft survival rivaling younger deceased donors, a 75-year-old represents an extreme. At 75:
- GFR declines at ~9 mL/min/1.73 m² per decade after age 40
- The donated kidney starts with a reduced nephron reserve
- Risk of DGF, faster progression of chronic allograft nephropathy, and shorter graft longevity are all substantially elevated
2. ABO Incompatibility - A Manageable Barrier
From Brenner and Rector's The Kidney:
"ABO-incompatible protocols now mostly entail a relatively short but intensive pretransplant regimen consisting of rituximab, IVIg, and plasmapheresis - continued until anti-A/B titers fall below a prespecified safe threshold (usually 1:8 or 1:16)... The long-term outcome of desensitized recipients of blood group incompatible organs is good although perhaps slightly inferior to that of ABO-compatible kidney transplant recipients, much of the excess risk being concentrated in the early post-transplant period."
A
2026 meta-analysis (Chen et al., PMID 41782862) pooling 18 studies and 15,611 recipients found:
- Short- to mid-term patient and graft survival in ABO-incompatible living donor kidney transplant (ABOi-LDKT) was comparable to ABO-compatible transplants in modern cohorts with desensitization.
- No significant difference in DGF, acute rejection, or surgical complications.
- Main downside: higher hospitalization costs due to desensitization procedures.
3. Head-to-Head Comparison
| Factor | 75-yr Mother (ABO compatible) | Younger Wife (ABO incompatible) |
|---|
| Blood group barrier | None | Requires desensitization (rituximab + plasmapheresis + IVIg) |
| Donor nephron reserve | Significantly reduced | Well-preserved (age-dependent) |
| Risk of delayed graft function | High | Low |
| Expected graft half-life | Shorter (nephron underdosing + aging) | Longer |
| Acute rejection risk | Lower (compatible match) | Slightly higher early post-transplant |
| Donor surgical risk | Higher (age-related perioperative risk) | Lower |
| Long-term graft survival | Inferior | Superior |
| Cost/complexity | Standard protocol | More complex and costly |
| Alternative: paired exchange? | Could keep mother as backup | Wife may not need desensitization if paired exchange possible |
4. Practical Considerations
-
Paired/Chain Exchange Programs: Before desensitizing, check if the wife can enter a kidney paired exchange program - she donates to a compatible recipient, and the patient gets a compatible kidney from another donor. This avoids desensitization entirely and may yield an even better-matched organ.
-
Anti-A/B Titer of Wife: If the recipient's anti-A/B titer is already low (e.g., A2 blood group donor into a B recipient), desensitization may be minimal or unnecessary.
-
HLA Matching: The mother, being a first-degree relative, may have better HLA matching. The wife may have no HLA sharing. However, with modern immunosuppression, HLA mismatch is much less impactful than donor age on outcomes.
-
Mother's Candidacy at 75: Most international guidelines and centers would carefully scrutinize or decline a 75-year-old donor due to reduced functional reserve. The donor evaluation (GFR, cardiovascular status, proteinuria, imaging) would need to be thorough.
-
KDIGO 2017 Living Donor Guidelines recommend against advanced-age donors with significant comorbidities, and a 75-year-old is at minimum a high-risk donor.
Summary
Choose the wife (ABO-incompatible but younger) - unless she has significant health issues of her own. A younger, healthy kidney with a manageable immunological barrier far outperforms an aged kidney from an otherwise "compatible" source. Donor age at 75 years is a substantial biological disadvantage that no degree of blood group compatibility can fully overcome. The ABO barrier, by contrast, is now routinely crossed with modern desensitization protocols with acceptable outcomes.
Sources: Brenner and Rector's The Kidney, p. 2977-2997; NKF Primer on Kidney Diseases 8e, p. 566-571; Bellini MI et al., J Nephrol 2022 [PMID 35072936]; Chen Y et al., Front Immunol 2026 [PMID 41782862]